[PDF][PDF] JAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of Down syndrome

…, Z Andrysik, MA Burchill, BAJ Tamburini, C Sempeck… - Cell reports, 2020 - cell.com
Individuals with Down syndrome (DS; trisomy 21) display hyperactivation of interferon (IFN)
signaling and chronic inflammation, which could potentially be explained by the extra copy of …

Androgen receptor regulates CD44 expression in bladder cancer

…, A Chauca-Diaz, C Owens, DE Hansel, C Sempeck… - Cancer research, 2021 - AACR
Colin SempeckSempeck: Writing–original draft, writing–review and editing, libraries
were designed and formulated. D. Ghosh: Formal analysis, writing–original draft, writing–review …

The APE2 nuclease is essential for DNA double-strand break repair by microhomology-mediated end joining

…, MK MacEachern, CM Stiefel, R Anand, C Sempeck… - Molecular Cell, 2023 - cell.com
Microhomology-mediated end joining (MMEJ) is an intrinsically mutagenic pathway of DNA
double-strand break (DSB) repair essential for proliferation of homologous recombination (…

JAK1 inhibition blocks lethal sterile immune responses: implications for COVID-19 therapy

…, R Minter, KA Waugh, P Araya, M Ludwig, C Sempeck… - BioRxiv, 2020 - biorxiv.org
Cytokine storms are drivers of pathology and mortality in myriad viral infections affecting the
human population. In SARS-CoV-2-infected patients, the strength of the cytokine storm has …

High-throughput drug screening combined with a druggable target CRISPR drop-out screen identifies therapeutic vulnerabilities of BCOR-CCNB3 fusion positive …

…, Y Murayama, H Umezu, M Joshi, C Sempeck… - Cancer Research, 2020 - AACR
Undifferentiated round cell sarcomas, which carry the BCOR-CCNB3 fusion gene, have
traditionally been called “Ewing-like sarcomas” and have been treated with Ewing sarcoma …

Integrative molecular and functional genomic analysis of chemotherapy resistant bladder cancer cell lines identifies novel mediators of therapeutic response

…, A Goodspeed, TD Laajala, M Joshi, C Sempeck… - Cancer Research, 2019 - AACR
Gemcitabine and cisplatin (GC) combination neoadjuvant chemotherapy (NAC) followed by
radical cystectomy (RC) is the standard of care for treating muscle-invasive bladder cancer (…

Functional genomic screening in gemcitabine and cisplatin resistant bladder cancer cell lines identifies DNA repair pathways as mediators of chemosensitivity

…, A Goodspeed, TD Laajala, M Joshi, C Sempeck… - Cancer Research, 2020 - AACR
4091: Functional genomic screening in gemcitabine and cisplatin resistant bladder cancer
cell lines identifies DNA repair pathways as mediators of chemosensitivity | Cancer Research …

Abstract B11: Multi-omic interrogation of gemcitabine and cisplatin-resistant bladder cancer cell lines identifies unique and shared mediators of chemosensitivity and …

…, A Goodspeed, TD Laajala, M Joshi, C Sempeck… - Clinical Cancer …, 2020 - AACR
Neoadjuvant platinum-based chemotherapy (NAC) followed by radical cystectomy is the
preferred first-line option for treating patients diagnosed with muscle-invasive bladder cancer (…

Abstract B51: MAPK regulation of an innate immune response in KRAS-mutant lung adenocarcinoma

…, L Marek, B Bullock, H Li, M Joshi, C Sempeck… - Molecular Cancer …, 2020 - AACR
Mutations in the KRAS oncogene are frequent in lung adenocarcinomas (LUADs).
Unfortunately, KRAS lacks a pharmacologically available inhibitor for precision oncology. …

JAK1 inhibition blocks lethal sterile immune responses: implications for COVID-19 therapy (preprint)

…, R Minter, K Waugh, P Araya, M Ludwig, C Sempeck… - 2020 - pesquisa.bvsalud.org
Cytokine storms are drivers of pathology and mortality in myriad viral infections affecting the
human population. In SARS-CoV-2-infected patients, the strength of the cytokine storm has …